REVIEW: There are many reasons for high blood pressure, high blood pressure is likely to cause stroke and cerebral infarction, thus threatening human life. High blood pressure can not be cured, only life-long medication, is there a way the same as the hepatitis B vaccine injection, steady blood pressure it? Division Pok home of the latest research allows us to see the hope of overcoming the high blood pressure. See [section] Secret Pok explore
hypertension vaccine in the near future, some patients with hypertension may be a single injection of vaccine, we can effective control of blood pressure. The therapeutic vaccine is a pharmaceutical company in Switzerland for many years R & D results. Currently, the vaccine is still in the small-scale clinical trials, there are 48 patients with hypertension have completed a course of injections, the antihypertensive effect can be expected for 4 months or so. It is reported that the vaccine will be listed within five years, research results have been published in the British Medical Pok journal system, into the body, the vaccine will be drugs compared to the pressure, high blood pressure vaccine has many advantages, first, the short half-life of oral antihypertensive drugs, not stability control early morning blood pressure, stroke and myocardial infarction at a time when it’s high time; high blood pressure vaccine is no such concerns, tests confirmed that the vaccine can guarantee early morning blood pressure decreased significantly in patients with the second vaccine injection three times a year just to avoid the trouble of taking a fixed daily, oral medication compliance was significantly better than the third, and now some high blood pressure is based on oral The principle treatment of angiotensin, but many patients feel little effect on their own blood pressure stop taking. there were adverse reactions after taking large, while high blood pressure vaccine side effects, only some flu-like symptoms, the patient more acceptable.
;-Japan Friendship Hospital, Ministry of Health, Department of Medicine and Cardiology, Director of Large Professor Keyuan Nan told . benefit from.
Keyuan Nan pointed out that both the United Kingdom or Switzerland, developed the vaccine, from the large-scale clinical trials have some distance, when approved through the market remains to be seen, entering China after six or seven years may be a matter of